title: Alpha-adrenergic Agonists for the Management of Opioid Withdrawal.
authors.affiliation: .
authors.forename: Matthew
authors.initials: M
authors.lastname: Royall
authors.affiliation: .
authors.forename: Kathryn K
authors.initials: KK
authors.lastname: Garner
authors.affiliation: .
authors.forename: Susan R
authors.initials: SR
authors.lastname: Hill
authors.affiliation: .
authors.forename: Matthew
authors.initials: M
authors.lastname: Barnes
mesh_terms: D058647:Adrenergic alpha-2 Receptor Agonists / Q000627:therapeutic use*; D018849:Controlled Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008691:Methadone / Q000627:therapeutic use; D009293:Opioid-Related Disorders / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D013375:Substance Withdrawal Syndrome / Q000534:rehabilitation*
chemical_list: D058647:Adrenergic alpha-2 Receptor Agonists; D008691:Methadone